Your contact persons
LARIAM®, with its active substance mefloquine, is a prescription-based travel medicine. It is indicated especially for therapy caused by strains of P. falciparum in which the pathogen has become resistant to other antimalarial agents. Additionally, it is indicated for travellers to malaria areas as part of chemoprophylaxis and stand-by treatment as an emergency measure when prompt medical attention is unavailable. Mefloquine is included in the WHO list of essential medicines and represents an important option of anti-malarial therapy in respect of globally emerging resistances against antimalarials.
Educational Material LARIAM®